Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 08 Dec 2025 08:00 CET |
PHOTOCURE | The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 19 Nov 2025 08:00 CET |
PHOTOCURE | New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 31 Oct 2025 08:24 CET |
PHOTOCURE | Photocure ASA: Notification of primary insider transaction | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 29 Oct 2025 07:00 CET |
PHOTOCURE | Photocure ASA: Results for the third quarter of 2025 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 24 Oct 2025 08:20 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of third quarter 2025 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 15 Oct 2025 17:08 CEST |
PHOTOCURE | Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 22 Sep 2025 08:23 CEST |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 04 Aug 2025 14:39 CEST |
PHOTOCURE | Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 30 Jul 2025 07:00 CEST |
PHOTOCURE | Photocure ASA: Results for the second quarter of 2025 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 22 Jul 2025 08:00 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of second quarter and first half year 2025 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 23 Jun 2025 14:55 CEST |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 08 May 2025 07:00 CEST |
PHOTOCURE | Photocure ASA: Results for the first quarter of 2025 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 05 May 2025 18:12 CEST |
PHOTOCURE | Photocure ASA: Annual general meeting held | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2025 20:57 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of first quarter 2025 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 29 Apr 2025 08:00 CEST |
PHOTOCURE | Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 11 Apr 2025 15:28 CEST |
PHOTOCURE | Photocure ASA - Notice of the Annual General Meeting 5 May 2025 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Apr 2025 15:20 CEST |
PHOTOCURE | Photocure ASA: Annual Report 2024 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 02 Apr 2025 08:50 CEST |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Acquisition or disposal of the issuer’s own shares |
| 31 Mar 2025 22:48 CEST |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Acquisition or disposal of the issuer’s own shares |
| 26 Mar 2025 08:55 CET |
PHOTOCURE | Photocure ASA - Share option grant to Vice President and General Manager EMEA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 26 Mar 2025 08:00 CET |
PHOTOCURE | Photocure appoints Jane Healy as Vice President and General Manager EMEA | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 24 Mar 2025 17:00 CET |
PHOTOCURE | Clinical data presentations at the European Association of Urology (EAU) 2025 congress highlight the benefits of using Blue Light Cystoscopy in bladder cancer | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 19 Mar 2025 18:00 CET |
PHOTOCURE | Photocure ASA: Initiation of a share buyback | 20103015 Pharmaceuticals | Acquisition or disposal of the issuer’s own shares |
| 14 Mar 2025 08:00 CET |
PHOTOCURE | New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 28 Feb 2025 15:51 CET |
PHOTOCURE | Photocure ASA – Major shareholding disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 28 Feb 2025 15:05 CET |
PHOTOCURE | NOTIFICATION OF MAJOR HOLDINGS | 20103015 Pharmaceuticals | Major shareholding notifications |
| 19 Feb 2025 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the fourth quarter of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 17 Feb 2025 17:00 CET |
PHOTOCURE | News on Richard Wolf/Photocure Collaboration: Interim Flexible BLC solution available in countries where System blue and Richard Wolf reusable flexible cystoscopes are cleared | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 17 Feb 2025 07:30 CET |
PHOTOCURE | Bladder Cancer: Upstaging and risk mitigation with Blue Light Cystoscopy in NMIBC featured at ASCO GU 2025 | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 12 Feb 2025 14:27 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2024 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 16 Jan 2025 08:46 CET |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 13 Jan 2025 08:00 CET |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 05 Jan 2025 08:47 CET |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Dec 2024 08:02 CET |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 19 Dec 2024 08:02 CET |
PHOTOCURE | Photocure ASA: Initiation of a share buyback | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2024 10:16 CET |
PHOTOCURE | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Dec 2024 15:14 CET |
PHOTOCURE | Photocure ASA: Notification of primary insider transaction | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 03 Dec 2024 07:00 CET |
PHOTOCURE | Photocure ASA: Notification of primary insider transaction | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 13 Nov 2024 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the third quarter of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 06 Nov 2024 16:48 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of third quarter 2024 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 05 Nov 2024 10:34 CET |
PHOTOCURE | Photocure Partner Asieris announces Marketing Approval by the National Medical Products Administration for Hexvix in China | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Sep 2024 08:00 CEST |
PHOTOCURE | Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 27 Sep 2024 08:00 CEST |
PHOTOCURE | Photocure establishes Named Patient Program to provide access to Hexvix in South Africa | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 17 Sep 2024 12:10 CEST |
PHOTOCURE | Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 16 Sep 2024 11:17 CEST |
PHOTOCURE | Notification of major shareholding | 20103015 Pharmaceuticals | Major shareholding notifications |
| 07 Aug 2024 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the second quarter of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 31 Jul 2024 12:00 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of second quarter and first half year 2024 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 15 Jul 2024 17:52 CEST |
PHOTOCURE | Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jun 2024 08:00 CEST |
PHOTOCURE | Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S. | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 23 May 2024 19:33 CEST |
PHOTOCURE | Photocure ASA - Annual general meeting held | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |